PCR analysis of human renal biopsies-Renin gene regulation in glomerul
onephritis. Animal studies show that the renin-angiotensin system cont
ributes to hypertension, glomerulosclerosis and progressive chronic re
nal failure in renal disease. Direct data on the activity of the renal
renin-angiotensin system (RAS) in human renal disease are scarce, how
ever. The small amount of tissue in renal biopsies and insufficient se
nsitivity of analytical methods have precluded reliable measurements o
f the tissue components of the RAS in the past. Due to its high sensit
ivity the quantitative polymerase chain reaction (QPCR) assay today al
lows the quantitation of gene transcription products in small tissue s
amples, for example, renal biopsies. The clinical applicability of the
PCR has raised the interest in this methodology. We adopted quantitat
ive PCR to study expression and regulation of the renin gene in patien
ts with different forms of glomerulonephritis. For PCR a deletion muta
nt of the renin gene was used as an internal standard exhibiting the s
ame primer binding sites as the human gene. The number of glomeruli pe
r biopsy sample was counted by microscopic transillumination immediate
ly after biopsy and was used as a reference base. Renin mRNA was expre
ssed as fg per glomerulus. Compared to nonaffected tissue of tumor nep
hrectomy samples, renin gene expression was significantly lower in glo
merulonephritic patients without converting enzyme inhibitor (CEI) tre
atment, that is, 63 +/- 20 (6) versus 250 +/- 50 (7) (P < 0.02), altho
ugh plasma renin concentration was in the normal range. Significantly
higher renin mRNA expression was found in patients with glomerulonephr
itis treated with CEI, that is, 210 +/- 50 (8) versus 63 +/- 20 (6) in
patients not treated. The data document (i) that quantitative PCR ass
ays permit determination of renin gene expression in human renal disea
se, and that (ii) expression of the renin gene is low early in the cou
rse of glomerulonephritis.